Education
About Us
Working with TipRanks
Follow Us
STELLA PHARMA CORPORATION (JP:4888)
:4888
RESEARCH TOOLSreports
4888 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥281.00 - ¥602.00
Previous CloseN/A
Volume163.70K
Average Volume (3M)302.97K
Market Cap
¥13.68B
Enterprise Value¥9.56B
Total Cash (Recent Filing)¥3.45B
Total Debt (Recent Filing)¥813.00M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
May 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-20.76
Shares Outstanding34,034,100
10 Day Avg. Volume332,700
30 Day Avg. Volume302,970
Financial Highlights & Ratios
PEG Ratio10.60
Price to Book (P/B)4.06
Price to Sales (P/S)0.00
P/FCF Ratio-13.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.86% Public Companies and
Individual Investors
4888 FAQ
What was STELLA PHARMA CORPORATION’s price range in the past 12 months?
STELLA PHARMA CORPORATION lowest stock price was ¥281.00 and its highest was ¥602.00 in the past 12 months.
What is STELLA PHARMA CORPORATION’s market cap?
STELLA PHARMA CORPORATION’s market cap is ¥13.68B.
When is STELLA PHARMA CORPORATION’s upcoming earnings report date?
STELLA PHARMA CORPORATION’s upcoming earnings report date is May 13, 2025 which is 32 days ago.
How were STELLA PHARMA CORPORATION’s earnings last quarter?
STELLA PHARMA CORPORATION released its earnings results on Feb 12, 2025. The company reported -¥3.06 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.06.
Is STELLA PHARMA CORPORATION overvalued?
According to Wall Street analysts STELLA PHARMA CORPORATION’s price is currently Overvalued.
Does STELLA PHARMA CORPORATION pay dividends?
STELLA PHARMA CORPORATION does not currently pay dividends.
What is STELLA PHARMA CORPORATION’s EPS estimate?
STELLA PHARMA CORPORATION’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does STELLA PHARMA CORPORATION have?
STELLA PHARMA CORPORATION has 34,034,100 shares outstanding.
What happened to STELLA PHARMA CORPORATION’s price movement after its last earnings report?
STELLA PHARMA CORPORATION reported an EPS of -¥3.06 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.835%.
Which hedge fund is a major shareholder of STELLA PHARMA CORPORATION?
Currently, no hedge funds are holding shares in JP:4888
Company Description
STELLA PHARMA CORPORATION
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.
Technical Analysis
RaQualia Pharma Inc.
―
Chiome Bioscience Inc.
―
Oncolys BioPharma, Inc.
―
StemRIM Inc.
―
CellSource Co., Ltd.
―